REVB’s valuation metrics: A comprehensive analysis

Revelation Biosciences Inc (REVB)’s stock has witnessed a price hike of 18.08% from the previous close with its current price standing at $0.39. Its current price is -96.58% under its 52-week high of $11.39 and 40.76% more than its 52-week low of $0.28. Based on the past 30-day period, the stock price is -29.75% below the high and +38.95% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, REVB’s SMA-200 is $0.7845.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


REVB’s price to book ratio for the most recent quarter was 0.28, resulting in an 0.18 price to cash per share for the period.

How does Revelation Biosciences Inc (REVB) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.

Revelation Biosciences Inc (REVB): Earnings History

If we examine Revelation Biosciences Inc’s recent earnings history, in the last quarter ended on 9/29/2023, it posted adjusted earnings per share of -$0.42, beating the consensus of -$0.3. In other words, it beat the consensus by -$0.12, resulting in a -40.00% surprise. In the 3 months period before the previous quarter which was closed on 9/29/2023, the stock recorded adjusted earnings per share of -$0.42 in contrast with the Outlook of -$0.3. That was a difference of -$0.12 and a surprise of -40.00%.

Revelation Biosciences Inc (REVB): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 2 different analysts, who are expecting earnings to fall in between the range of -0.27 and -0.46 with an average Earnings Estimate of -0.37 which is in contrast with the last year earnings estimate of -1.77 and also replicates 79.10% growth rate year over year.

Revelation Biosciences Inc (NASDAQ: REVB) Ownership Details

I will give a breakdown of the key shareholders in Revelation Biosciences Inc (REVB). Recent figures show that the company’s insiders hold 2.53% of shares. A total of 14 institutional investors hold shares in the company, making 18.66% of its stock and 19.15% of its float.

Sep 29, 2023, it was reported that the Company’s largest institutional holder is Sabby Management, LLC holding total of 0.4 million shares that make 6.40% of the company’s total number of shares and are currently priced at 0.15 million.

The securities firm Citadel Advisors Llc holds 57360.0 shares of REVB, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.91%, and the holding percentage of shares is valued at 21389.0.

An overview of Revelation Biosciences Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Revelation Biosciences Inc (REVB) traded 198,374 shares per day, with a moving average of $0.4618 and price change of -0.1491. With the moving average of $0.5529 and a price change of -0.1979, about 125,358 shares changed hands on average over the past 50 days. Finally, REVB’s 100-day average volume is 92,939 shares, alongside a moving average of $0.6145 and a price change of -0.3053.

Related Posts